Articles Tagged With:
-
Clinical Briefs in Primary Care supplement
-
Abstract & Commentary: Patients/Surrogates Vastly Overrate Likelihood of Survival after Cardiac Arrest
Participants in this study were 100 patients/surrogates and their physicians in a 26-bed medical ICU located in an academic medical center. -
Abstract & Commentary: Low Tidal Volume Ventilation in theAbsence of Acute Lung Injury: A Study in Post-Cardiac Surgery Patients
Supported by robust data from numerous clinical trials, low-tidal-volume ventilation is now standard-of-care in managing patients with acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS). -
Critical Care Alert August 2011 Issue in PDF
-
Abstract & Commentary: The Impact of Establishing a Regional Weaning Unit for Patients Requiring Prolonged Mechanical Ventilation
Although most critically ill patients require only short periods of respiratory support, a minority require prolonged mechanical ventilation (PMV). -
Pharmacology Watch: FDA issues Multiple Drug Warnings
-
The Broken Heart: It CAN Be Mended
The authors advocate that cardiovascular magnetic resonance imaging using specific criteria may be useful as a diagnostic tool for patients with stress cardiomyopathy at the time of acute clinical presentation. -
Internal Medicine Alert - Full August 29, 2011 Issue in PDF
-
Ticagrelor Tablets (Brilinta™)
A third oral antiplatelet inhibitor has been approved by the FDA to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). Ticagrelor is an adenosine diphosphate receptor P2Y12 inhibitor similar to clopidogrel and prasugrel. It is marketed by AstraZeneca as Brilinta. -
Clinical Briefs By Louis Kuritzky, MD
Since two-thirds of americans are overweight or obese, most of us should probably be trying to better understand why.